IcoSema

insulin icodec and semaglutide · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for IcoSema, covering 2025-01-17 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4) [Phase 3]

See pricing